A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
A phase 1 open-label dose escalation study of OMP-21M18 in subjects with previously treated
solid tumour for which there is no remaining standard curative therapy and no therapy with a
demonstrated survival benefit.